Wall Street ends the week at its lows. The Nasdaq just had its worst week since June, the semiconductor index has fallen eight sessions in a row, and small caps gave back Thursday’s bounce. That makes the stocks to watch tomorrow a mix of one scheduled catalyst, Cleveland-Cliffs’ earnings before the open, and a group of small caps still digesting news-driven jumps. Here are the top stocks to watch tomorrow, with Friday’s closes, key levels and both sides of every trade.
Today’s Market Snapshot: Nasdaq Sinks 4.5% in Its Worst Week Since June
| Index | Oct 16 Close | Day Move | Week | Oct 15 Close |
|---|---|---|---|---|
| S&P 500 | 7,659.44 | –1.09% | –1.95% | 7,744.06 |
| Nasdaq Composite | 26,140.03 | –2.14% | –4.48% | 26,713.02 |
| Dow Jones | 52,002.41 | –0.34% | +0.67% | 52,177.69 |
| Russell 2000 | 2,721.37 | –1.66% | –3.0% | ~2,767 |
Yahoo Finance’s closing recap tied the slide to AI-linked selling, and ABC News reported Micron down 5.6% and Intel down 5.8%. The Investrade market review noted that Friday broke a 55-day streak without a 1% S&P 500 drop, and that the 10-year yield settled near 5.10%. The Market Breakdown added that 68 of the S&P’s 75 tech stocks fell while Brent rose 3.7% to about $109.86.
For Monday, Earnings Whispers lists Cleveland-Cliffs, Fifth Third and SmartFinancial before the open, with Steel Dynamics, AGNC, Crown and BOK Financial after the close. Netflix and SpaceX follow Tuesday, Meta and Tesla Wednesday, per CNBC’s preview.
Data note: Closes come from Stock Titan’s monthly movers board, which lists “price now” as of Oct 16. Percent moves are computed from consecutive closes. Support and resistance levels are analytical zones, not guaranteed targets.
Stocks to Watch Tomorrow: The 10-Stock Watchlist for Monday, Oct 19
1. Cleveland-Cliffs (CLF) | Earnings Before Market Open
The Steel Turnaround Test: Can a $0.24 Profit Replace a $145 Million Loss?
| Metric | Data |
|---|---|
| Last Verified Close | $12.19 (Oct 15, +1.1%); Friday’s close not confirmed |
| 52-Week Range | $7.73 – $16.70 |
| Market Cap | ~$6.9B |
| Q3 Consensus | EPS $0.24 (vs. –$0.45 a year ago); revenue $5.72B |
| Last Quarter | Q2 net loss $145M on $5.2B revenue |
| Analysts | Mostly Hold; consensus target ~$11.96 (range $10–$15.60); Wells Fargo upgraded to Overweight, $14 |
| Support 1 / 2 | ~$11.50 / ~$10.00 |
| Resistance 1 / 2 | ~$12.44 / ~$14.00 |
Catalyst: Benzinga’s preview puts the report before the open Monday. Technicals: The stock jumped 10% to $12.44 on Oct 5, per 24/7 Wall St, so $12.44 is the level to reclaim. Fundamentals: A swing to profit is already expected.
- Bull: Higher steel prices, an upgrade and a beaten-down chart.
- Bear: Stelco fallout, heavy debt and a Street that mostly sits on Hold.
Forecast: A beat with firm guidance targets $12.44, then $14. A miss puts $11.50 in play. What to Watch: Shipment guidance and cash flow.
Why this matters: It is the first scheduled test of the steel rebound.
2. Quantum X Labs (QXL) | +13.7% to $4.41
The IBM Quantum Hardware Test That Lit Up a $95 Million Name
| Metric | Data |
|---|---|
| Last Close | $4.41 |
| Previous Close | $3.88 |
| Day Move | +$0.53 (+13.7%) |
| Day Range | $4.12 – $4.54 (open $4.22) |
| Volume | 162,659 shares (3.6x relative) |
| Market Cap | ~$95.1M |
| Support 1 / 2 | $4.12 / $3.88 |
| Resistance 1 / 2 | $4.54 / ~$5.00 |
Catalyst: The company said its cybersecurity technology achieved a significant breakthrough on IBM Quantum hardware. Technicals: It closed in the upper half of its range. Fundamentals: I could not verify analyst coverage.
- Bull: A quantum-security theme with a named partner.
- Bear: Tiny volume, and a press-release catalyst.
Forecast: A close above $4.54 opens $5. A loss of $4.12 refills the gap toward $3.88. What to Watch: Whether volume expands past 162K.
Why this matters: It is a clean read on how small quantum names trade after Wednesday’s rotation.
3. SITE Centers (SITC) | +13.95% to $3.43
The $3 Payout Trade: A REIT That Is Mostly a Distribution
| Metric | Data |
|---|---|
| Last Close | $3.43 |
| Previous Close | $3.01 |
| Day Move | +$0.42 (+13.95%) |
| Day Range | $3.42 – $3.65 (open $3.59) |
| Volume | 10.1M shares (8.3x relative) |
| Market Cap | ~$180M |
| Distribution | $3.00 per share, payable Nov 5 |
| Support 1 / 2 | $3.42 / $3.01 |
| Resistance 1 / 2 | $3.59 / $3.65 |
Catalyst: SITE Centers announced the sale of its DTP interests and the special distribution, and a plan to delist from the NYSE. Technicals: It gapped to $3.59 and closed near the low. Fundamentals: The company has paid out special dividends since its 2023 spin-off plan.
- Bull: The $3.00 payout is about 87% of Friday’s close.
- Bear: The share price should fall by roughly the payout when it trades ex-distribution, and delisting cuts liquidity.
Forecast: Holding $3.42 keeps the payout trade alive. A break toward $3.01 means the gap is fading. What to Watch: The record and ex-dates in the company’s filings.
Why this matters: It shows how liquidation-style REITs can trade almost entirely on the payout.
4. Humacyte (HUMA) | –2.4% to $0.4290
The Sub-$1 Biotech Giving Back Part of a 24% Jump
| Metric | Data |
|---|---|
| Last Close | $0.4290 |
| Previous Close | $0.4395 (Oct 15, +24.12% from $0.3541) |
| Day Move | –$0.0105 (–2.4%) |
| Oct 15 Range | $0.3512 – $0.4456 |
| Volume (Oct 15) | 20.8M shares (4.5x relative) |
| Market Cap | ~$100M–$130M (sources differ) |
| Analysts | Moderate Buy; consensus target $5.68 (Oct 9) |
| Support 1 / 2 | ~$0.41 / $0.3541 |
| Resistance 1 / 2 | $0.4395 / $0.4456 |
Catalyst: Humacyte’s update highlighted faster hospital adoption of Symvess. Technicals: It held most of Thursday’s gain. Fundamentals: MarketBeat lists a target far above the price.
- Bull: Rising adoption, a heavy-volume breakout and a high Street target.
- Bear: A price far below Nasdaq’s $1 minimum bid, which typically invites reverse-split risk.
Forecast: A close above $0.4456 targets $0.50. Below $0.41 points back to $0.3541. What to Watch: Volume versus Thursday’s 20.8M.
Why this matters: It tests whether commercial traction can hold a sub-$1 rally.
5. Better Home & Finance (BETR) | –7.5% to $9.95
The Yaccarino Spike Cools After a 32% Surge
| Metric | Data |
|---|---|
| Last Close | $9.95 |
| Previous Close | $10.76 (Oct 15, +32.5% from $8.12) |
| Day Move | –$0.81 (–7.5%) |
| Oct 15 Range | $8.05 – $11.37 |
| Volume (Oct 15) | 3.38M shares (6.2x relative) |
| Market Cap | ~$189M |
| Support 1 / 2 | ~$9.50 / $8.12 |
| Resistance 1 / 2 | $10.76 / $11.37 |
Catalyst: Better named former X CEO Linda Yaccarino to its board. Technicals: It closed near the middle of Thursday’s range after fading. Fundamentals: I could not verify analyst targets.
- Bull: A high-profile addition and lower yields helping mortgage names.
- Bear: A board appointment is not earnings.
Forecast: Above $9.50 the bounce stays constructive. A loss of $9.50 reopens $8.12. What to Watch: The 10-year yield near 5.1%.
Why this matters: Housing-finance names react to rates first and news second.
6. MaxCyte (MXCT) | Flat at $1.30
The Guidance Raise That Is Holding Its 35% Gain
| Metric | Data |
|---|---|
| Last Close | $1.30 |
| Previous Close | $1.30 (Oct 15); $1.25 on Oct 14 (+29.6% from $0.9643) |
| Day Move | Unchanged |
| Oct 14 Range | $1.20 – $1.33 |
| Volume (Oct 14) | 12.7M shares (43.4x relative) |
| Market Cap | ~$134M |
| Support 1 / 2 | $1.25 / $0.9643 |
| Resistance 1 / 2 | $1.33 / ~$1.50 |
Catalyst: MaxCyte reported preliminary Q3 revenue and raised its 2026 revenue guidance. Technicals: Two straight closes at $1.30. Fundamentals: Analyst data was not verified.
- Bull: A guidance raise and a stock holding gains.
- Bear: Preliminary figures and a small float.
Forecast: A close above $1.33 targets $1.50. A loss of $1.25 puts the gap at risk. What to Watch: Any follow-up from the Street.
Why this matters: Holding gains after a guidance raise is a sign buyers still care.
7. Opko Health (OPK) | –5.0% to $1.53
Labcorp’s BioReference Deal Pop Fades
| Metric | Data |
|---|---|
| Last Close | $1.53 |
| Previous Close | $1.61 (Oct 15, +17.5% from $1.37) |
| Day Move | –$0.08 (–5.0%) |
| Oct 15 Range | $1.48 – $1.70 |
| Volume (Oct 15) | 55.3M shares (31x relative) |
| Market Cap | ~$1.14B |
| Support 1 / 2 | $1.48 / $1.37 |
| Resistance 1 / 2 | $1.61 / $1.70 |
Catalyst: Labcorp agreed to acquire select BioReference Health assets. Technicals: It gave back about a third of the gain. Fundamentals: Analyst targets were not verified.
- Bull: An asset sale that clarifies the business.
- Bear: Sellers are fading the deal.
Forecast: A hold of $1.48 keeps the gap intact. Below it, $1.37 is the pre-news close. What to Watch: Deal terms and closing timeline.
Why this matters: It is a live test of whether deal pops stick in a weak tape.
8. The RealReal (REAL) | –1.4% to $10.39
The Refinancing Rally Consolidates Near $10.50
| Metric | Data |
|---|---|
| Last Close | $10.39 |
| Previous Close | $10.54 (Oct 15, +15.8% from $9.10) |
| Day Move | –$0.15 (–1.4%) |
| Oct 15 Range | $9.34 – $10.55 |
| Volume (Oct 15) | 5.9M shares (2.3x relative) |
| Market Cap | ~$1.26B |
| Support 1 / 2 | ~$10.00 / $9.10 |
| Resistance 1 / 2 | $10.55 / ~$11.00 |
Catalyst: The company refinanced its 2029 notes with a $150M term loan and a $25M revolver. Technicals: It closed within 2% of its Thursday high. Fundamentals: Analyst data was not verified. For how small, volatile names behave around catalysts, see our penny-stock watchlist.
- Bull: Better debt terms and tight consolidation.
- Bear: Heavily rate-sensitive, and the run is recent.
Forecast: A close above $10.55 targets $11. A loss of $10.00 reopens $9.10. What to Watch: Yields and the earnings date.
Why this matters: It shows a balance-sheet fix can matter as much as sales.
9. NeurAxis (NRXS) | –0.5% to $7.70
Coverage for 26 Million More Lives, Held at the Highs
| Metric | Data |
|---|---|
| Last Close | $7.70 |
| Previous Close | $7.74 (Oct 15, +18.5% from $6.53) |
| Day Move | –$0.04 (–0.5%) |
| Oct 15 Range | $6.80 – $7.84 |
| Volume (Oct 15) | 1.13M shares (12.2x relative) |
| Market Cap | ~$96.7M |
| Support 1 / 2 | ~$7.00 / $6.53 |
| Resistance 1 / 2 | $7.84 / ~$8.50 |
Catalyst: NeurAxis announced a medical policy coverage milestone adding access to 26 million covered lives. Technicals: It closed within 2% of its high. Fundamentals: Analyst data was not verified.
- Bull: Wider payer access and a tight close.
- Bear: Thin volume and a micro-cap float.
Forecast: A close above $7.84 targets $8.50. A loss of $7.00 reopens the gap. What to Watch: Follow-up volume.
Why this matters: Coverage wins are what turn a device story into revenue.
10. Marwynn Holdings (MWYN) | +14.5% to $2.21
The AI-Computing MOU Squeeze, Up 60% Since the News
| Metric | Data |
|---|---|
| Last Close | $2.21 |
| Previous Close | $1.93 (Oct 15) |
| Day Move | +$0.28 (+14.5%) |
| Since Pre-News | +59.8% (from $1.38 on Oct 12) |
| Volume (Oct 13) | 295K shares (4.7x relative) |
| Market Cap | ~$44.5M |
| Support 1 / 2 | ~$1.93 / $1.60 |
| Resistance 1 / 2 | ~$2.50 / ~$3.00 |
Catalyst: Marwynn signed an MOU with OmniX to explore AI computing and RWA securities infrastructure. Technicals: Three straight gains. Fundamentals: An MOU is non-binding exploration.
- Bull: Momentum, a hot theme and a thin float.
- Bear: Micro-cap, non-binding news and a 60% run that can reverse fast.
Forecast: A close above $2.50 targets $3. A loss of $1.93 points to $1.60. What to Watch: Volume and any binding agreement.
Why this matters: It shows how fast a small cap can run on a thin story. For a similar setup, see our small-cap biotech breakdown.
Sector Sentiment Snapshot and Forecast
Money moved out of AI hardware and into defensives. The Market Breakdown noted energy gaining while tech sold off, and Investrade reported the equal-weighted S&P had its best week against tech since 2009. Small caps lost 3% for the week, so follow-through in the names above is not guaranteed. CoreWeave’s roughly $50 billion debt load is the clearest example of the AI-credit worry. Forecast: Expect a choppy open. The key tests are the 10-year yield near 5.1%, oil near $110 Brent, and Cleveland-Cliffs’ report. See our September trending-stocks recap and our Aug 7 watchlist for how risk-off weeks played out earlier.
Stocks to Watch Tomorrow: At a Glance
| # | Stock | Last Close | Move | Key Levels | Catalyst |
|---|---|---|---|---|---|
| 1 | CLF | $12.19 (Oct 15) | +1.1% | $11.50 / $12.44 | Q3 earnings, before open |
| 2 | QXL | $4.41 | +13.7% | $4.12 / $4.54 | IBM quantum test |
| 3 | SITC | $3.43 | +13.95% | $3.42 / $3.59 | $3.00 distribution |
| 4 | HUMA | $0.4290 | –2.4% | $0.41 / $0.4456 | Symvess adoption |
| 5 | BETR | $9.95 | –7.5% | $9.50 / $10.76 | Board addition |
| 6 | MXCT | $1.30 | 0.0% | $1.25 / $1.33 | Guidance raise |
| 7 | OPK | $1.53 | –5.0% | $1.48 / $1.61 | Labcorp deal |
| 8 | REAL | $10.39 | –1.4% | $10.00 / $10.55 | Refinancing |
| 9 | NRXS | $7.70 | –0.5% | $7.00 / $7.84 | Payer coverage |
| 10 | MWYN | $2.21 | +14.5% | $1.93 / $2.50 | AI-computing MOU |
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, high-volatility stocks carry elevated risk. Stock prices, percentage moves, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.
About The Author
